|
|
 |
 |
|
|
|
|
(Diabetes Mellitus--Continued from page
1)
For a newly diagnosed feline DM patient I choose between insulin and an oral hypoglycemic
agent. An oral hypoglycemic agent is more likely to work in an obese cat. The majority of
the time I use insulin - certainly I do this if there is already neuropathy or if there is
a history of ketosis or marked weight loss. I usually start with human recombinant
insulin, usually NPH, although other veterinarians use Lente or Ultralente with success,
proving that there is not really a "wrong" type to start with (although
absorption of ultralente can be problematic in some cats). I generally reserve beef PZI
for cases that are not doing well on the other types of insulin. Almost all cats
need BID insulin, so I generally start with 1 unit BID and work upwards from there. The
site of insulin administration is varied to prevent fibrosis at one site (leading to
subsequent poor absorption) and thick skinned/fatty areas of the body are avoided. A new
bottle should be purchased every 2-3 months.
If I decide to use an oral hypoglycemic agent, I usually use glipizide (dose 2.5 to 5 mg
PO BID), but other choices are glimiperide (1-2 mg PO SID) and acarbose (12.5 mg PO BID).
Glipizide and glimiperide work by promoting insulin release and increasing insulin
receptor sensitivity. The side effects are not that common but include anorexia, vomiting
and liver disease. Giving the drug with food helps to reduce side effects. Acarbose is
another oral hypoglycemic drug and although I haven't used it much, I have seen a few
patients do quite well with this medication. Acarbose works by impairing carbohydrate
digestion and subsequently glucose absorption from the intestine. Side effects are
flatulence and diarrhea. Don't use metformin in cats - it doesn't work well and it has
severe side effects. I usually don't give insulin and oral hypoglycemics together.
I send the owner home with ketodiastix to monitor the urine several times a week. Here I
am looking for ketonuria (if present, the client should call immediately) and the absence
of glucose in the urine. If the latter occurs for more than several days in a row, then a
dose reduction of insulin needs to be considered. I NEVER increase the insulin dose based
on a urine glucose concentration alone.
When starting insulin therapy in a newly diagnosed diabetic cat, I usually monitor the
blood glucose (BG) several times per day after the first dose of insulin. I do this
to make sure that hypoglycemia does not occur. I may do a glucose curve near the beginning
of treat
|
|
|
|
|
 |
 |
|
 |
 |
|
|
|
|
ment mainly to assess the duration of
effect of the insulin. This has to be interpreted cautiously. We all know about the
possible effect of stress on BG measurements in our patients. Another word of
warning about glucose curves comes from a research abstract at the ACVIM conference last
year which showed that a glucose curve can vary a huge amount on 2 consecutive days. In
fact, treatment recommendations in the patients studied were different 65% of the time
depending on which curve was assessed. In the majority of patients, the
recommendations were completely opposite (i.e. one curve suggested a decrease in dose was
needed but the curve the following day suggested an increase in the dose was needed!).
In cats I try to rely on fructosamine concentrations and "spot" BGs taken 6-8
hours after the insulin dose. I do these 2 tests together every 3-4 weeks or until
control is adequate, then 2 to 4 times per year. Fructosamine reflects the overall BG in
the last 2-3 weeks. I aim for fructosamine < 400 mg/dl and a BG < 180 mg/dl. If
fructosamine is ideal, but BG is high, this probably just reflects a stressed cat at
venipuncture. If both are high, the insulin dose is increased and if the BG and
fructosamine are low, the insulin dose is reduced. If the BG is low, but the fructosamine
is high, I might suspect that owner compliance is not optimal at home (i.e. missing doses
of insulin on some days but doing a great job on the day that the cat needs to visit the
vet).
Finally, one of the things that I have learned about feline diabetics is to not
"over-control" them. Definitely I want to avoid ketoacidosis, marked weight
fluctuations, excessive PU/PD and polyneuropathy, but I also want to avoid hypoglycemia. I
think that it is very important to take a step back from the patient and base a lot of
decisions on attitude, appetite, severity of PU/PD and body weight rather than getting
bogged down with laboratory data.
|
|
|
|
|
 |
 |
|
|